Long-term follow-up after purine analogue therapy in hairy cell leukaemia
Open Access
- 1 December 2015
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 28 (4) , 217-229
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Long-term results for pentostatin and cladribine treatment of hairy cell leukemiaLeukemia & Lymphoma, 2011
- Alternative methods of cladribine administrationLeukemia & Lymphoma, 2011
- Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrenceLeukemia & Lymphoma, 2011
- How I treat hairy cell leukemiaBlood, 2010
- VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapyBlood, 2009
- Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behaviorBlood, 2009
- Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosisBritish Journal of Haematology, 2009
- An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosineLeukemia, 2004
- Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patientsLeukemia, 2003
- Lasting Remissions in Hairy-Cell Leukemia Induced by a Single Infusion of 2-ChlorodeoxyadenosineNew England Journal of Medicine, 1990